Pivotal Phase 3 Trial Met Primary and Multiple Key Secondary Efficacy Endpoints; Favorable Safety and Tolerability Demonstrated ARC-HD Trial Shows... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=53876
Custom Search PHENOGEN SCIENCES, INC. ANNOUNCES CLINICAL VALIDATION STUDY SUPPORTING THE USE OF BREVAGENPLUS(R) IN BREAST CANCER RISK... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=53843
MP Biomedicals, LLC, a leading provider of life science reagents, fine chemicals and diagnostic products, has received the US Food and Drug... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=85651&sid=2
Picture for representational purpose Scientists have designed the world's first 'bionic bra' that automatically adjusts itself in response to the... ...http://indiatoday.intoday.in/story/worlds-first-bionic-bra-adjusts-to-breast-movement/1/406829.html
From the Wires Dec. 11, 2014 10:14 AM LONDON and NEW YORK , December 11, 2014 /PRNewswire/ -- Breast cancer, one of the most common... ...http://in.sys-con.com/node/3260102
Radiation therapy (in American...